ERA Consulting UK Ltd
The ERA Consulting Group is one of the longest established and most experienced regulatory affairs and product development consulting groups serving the biopharmaceutical industry.
Our expertise covers quality, nonclinical and clinical aspects, both from the regulatory and development strategy perspective. ERA has the knowledge and experience to assist from conception to registration, and beyond.
ERA has experience with a wide range of products (over 450 products to date), including recombinant DNA and hybridoma technology, synthetic peptides, conventional and advanced vaccines, classical blood products, advanced therapy medicinal products comprising gene therapy, somatic cell therapy and tissue-engineered products. ERA also works with innovative new chemical entities, particularly those indicated for neurological, oncological and immunological diseases.
Our specialised international team of more than 30 full-time professionals includes scientists with a research and development background, those with extensive industry experience and former regulators, offering both breadth and depth of expertise, from which our clients can benefit.
Dr Tara SandersonDirector of Regulatory Affairs - CMC Biologics
Ms Laura CanalejasBusiness Development Assistant
Manchester Science Partnerships
Alderley Park is the leading life science facility in the North of England and the largest R&D campus of its kind in the UK, offering over 1.5m sq ft of scientific, laboratory, office and conferencing space. With over £550m invested by AstraZeneca in world-class facilities and infrastructure over the past decade, it is the single best-invested full spectrum drug discovery and development campus in the UK, with an unrivalled talent pool of science professionals available in the area.